Earlier Referral May Expand Access to Melanoma Cellular Therapy
A faculty panel advises earlier referral for advanced melanoma cellular therapy and explains why brain metastases or prior immune toxicity need not end candidacy.
Topic
Topic
A faculty panel advises earlier referral for advanced melanoma cellular therapy and explains why brain metastases or prior immune toxicity need not end candidacy.